BRCA NEWSWORTHY

Experimental cancer drugs cut tumors off from repair tools by Liz Szabo

Follow this link: http://www.usatoday.com/news/health/2009-05-27-asco-cancer-drugs_N.htm

These new experimental cancer drugs are called PARP inhibitors & they are being used in women whose tumors don’t respond well to hormones or Herceptin. These drugs are being studied in BRCA positive patients as well as cancer patients. BRCA patients have the mutated gene that is supposed to repair or fix damaged DNA—therefore when the repair doesn’t work properly mistakes in the DNA accumulate, do not repair & cancer develops. Apparently these PARP inhibitors are a repair enzyme that clean up & repair these damaged cells.